 |
2 Products |  |
0 Diseases | | 2 Products |
|
3 Trials |  |
82 News |  |
| «12 |
- | sunitinib maleate (GB-102) / CalciMedica
Enrollment closed: A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion (clinicaltrials.gov) - Nov 6, 2019
P2a, N=21, Active, not recruiting, Sponsor: Graybug Vision
Recruiting --> Active, not recruiting
- | Auxora (zegocractin) / CalciMedica
Trial completion: A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis (clinicaltrials.gov) - Sep 19, 2019
P2, N=7, Completed, Sponsor: CalciMedica, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | sunitinib maleate (GB-102) / CalciMedica
Enrollment open: ALTISSIMO: A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD (clinicaltrials.gov) - Sep 11, 2019
P2b, N=220, Recruiting, Sponsor: Graybug Vision
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | sunitinib maleate (GB-102) / CalciMedica
New P2a trial: A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion (clinicaltrials.gov) - Sep 11, 2019
P2a, N=20, Recruiting, Sponsor: Graybug Vision
- |||||| sunitinib maleate (GB-102) / CalciMedica
New P2b trial: ALTISSIMO: A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD (clinicaltrials.gov) - May 15, 2019
P2b, N=220, Not yet recruiting, Sponsor: Graybug Vision
- || Auxora (zegocractin) / CalciMedica
Trial completion: CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS (clinicaltrials.gov) - May 3, 2019
P2, N=21, Completed, Sponsor: CalciMedica, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Auxora (zegocractin) / CalciMedica
Enrollment closed: A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis (clinicaltrials.gov) - Mar 14, 2019
P2, N=7, Active, not recruiting, Sponsor: CalciMedica, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Auxora (zegocractin) / CalciMedica
Enrollment closed: CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS (clinicaltrials.gov) - Feb 25, 2019
P2, N=21, Active, not recruiting, Sponsor: CalciMedica, Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Auxora (zegocractin) / CalciMedica
Enrollment open: A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis (clinicaltrials.gov) - Jan 31, 2019
P2, N=5, Recruiting, Sponsor: CalciMedica, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Auxora (zegocractin) / CalciMedica
New P2 trial: A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis (clinicaltrials.gov) - Oct 17, 2018
P2, N=5, Not yet recruiting, Sponsor: CalciMedica, Inc.
- | Auxora (zegocractin) / CalciMedica
Enrollment open: CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS (clinicaltrials.gov) - Apr 13, 2018
P2, N=24, Recruiting, Sponsor: CalciMedica, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Auxora (zegocractin) / CalciMedica
New P2 trial: CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS (clinicaltrials.gov) - Jan 17, 2018
P2, N=24, Not yet recruiting, Sponsor: CalciMedica, Inc.